Long-term safety and efficacy of pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in relapsed and refractory multiple myeloma (RRMM) patients enrolled in the MM-002 phase II trial.
David Samuel DiCapua Siegel
Honoraria - Celgene; Merck; Millennium; Onyx
Paul Gerard Guy Richardson
Consultant or Advisory Role - Celgene; Johnson & Johnson; Millennium
Ravi Vij
Consultant or Advisory Role - Celgene; Onyx
Honoraria - Celgene; Millennium; Onyx
Research Funding - Celgene; Onyx
Craig C. Hofmeister
Consultant or Advisory Role - Celgene
Research Funding - Celgene; Merck; Millennium; Oncolytics Biotech
Rachid C. Baz
Research Funding - Bristol-Myers Squibb; Celgene; Millennium; Sanofi
Sundar Jagannath
Consultant or Advisory Role - Celgene; Merck Sharp & Dohme; Millennium; Onyx
Honoraria - Celgene; Merck Sharp & Dohme; Millennium; Onyx
Christine Chen
Honoraria - Celgene
Research Funding - Celgene
Sagar Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis; Onyx; Sanofi
Andrzej J. Jakubowiak
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Honoraria - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Nizar J. Bahlis
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Kevin W. Song
Consultant or Advisory Role - Celgene; Janssen
Honoraria - Celgene; Janssen
Research Funding - Celgene; Janssen
Andrew Belch
No relevant relationships to disclose
Noopur S. Raje
Consultant or Advisory Role - Amgen; Celgene; Novartis
Research Funding - Acetylon Pharmaceuticals; AstraZeneca
Chaim Shustik
Consultant or Advisory Role - Celgene
Suzanne Lentzsch
Consultant or Advisory Role - Celgene
Research Funding - Celgene
Min Chen
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Mohamed H. Zaki
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Kenneth Carl Anderson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Other Remuneration - Acetylon Pharmaceuticals; OncoPep